DOI: https://dx.doi.org/10.18565/epidem.2020.10.3.116-22
Мурзакова А.В., Киреев Д.Е.
ФБУН «Центральный НИИ эпидемиологии» Роспотребнадзора, Москва, Россия
1. Technical update on HIV incidence assays for surveillance and monitoring purposes. Geneva: World Health Organization (WHO), UNAIDS; 2015. 2. Guidelines on monitoring the impact of the HIV epidemic using population-based surveys. Geneva: World Health Organization (WHO), UNAIDS; 2015. 3. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: World Health Organization (WHO), UNAIDS; 2011. 4. WHO Technical Working Group on HIV Incidence Assays: Meeting Report, 2009. 5. WHO/UNAIDS annual meeting of the Technical Working Group on HIV Incidence Assays. 13–15 October 2014, Barcelona, Spain. Geneva: World Health Organization, 2015. 6. Global HIV strategic information working group. Recent infection testing algorithm technical update. Applications for HIV surveillance and programme monitoring, Geneva: World Health Organization (WHO), UNAIDS; 2018. 7. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L. et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17(13): 1871–9. DOI: 10.1097/00002030-200309050-00005 8. Cohen M.S., Gay C.L., Busch M.P., Hecht F.M. The detection of acute HIV infection. J. Infect. Dis. 2010; 202: 270–7. DOI: 10.1086/655651 9. Smoleń-Dzirba J., Wąsik T.J. Current and future assays for identifying recent HIV infections at the population level. Med. Sci. Monit. 2011; 17(5): RA124-133. DOI: 10.12659/msm.881757 10. Murphy G., Parry J.V. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 2008; 13(36): 4–10. 11. Moyo S., Wilkinson E., Novitsky V., Vandormael A., Gaseitsiwe S., Essex M. et al. Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses 2015; (7): 5508–24. DOI: 10.3390/v7102887 12. Kassanjee R., Pilcher C.D., Busch M.P., Murphy G., Facente S.N., Keating S.M. et al. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS 2016; 15(30): 2361–71. DOI: 10.1097/QAD.0000000000001209 13. Robinson E., Moran J., O’Donnell K., Hassan J., Tuite H., Ennis O. et al. Integration of a recent infection testing algorithm into HIV surveillance in Ireland: improving HIV knowledge to target prevention. Epidemiology and Infection 2019; 147(e136): 1–7. DOI: https://doi.org/10.1017/ S0950268819000244 14. Janssen R.S., Satten G.A., Stramer S.L., Rawal B.D., O’Brien T.R., Weiblen B.J. et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280(1): 42–8. DOI: 10.1001/jama.280.1.42 15. Suligoi B, Galli C, Massi M., Di Sora F., Sciandra M., Pezzotti P. et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. 2002; 40: 4015–20. DOI: 10.1128/jcm.40.11.4015-4020.2002 16. Grebe E., Welte A., Hall J., Keating S.M., Facente S.N., Marson K. et al. Infection staging and incidence surveillance applications of high dynamic range diagnostic immunoassay platforms. AIDS 2017; 76(5): 547–55. DOI: 10.1097/QAI.0000000000001537 17. Parekh B.S., Kennedy M.S., Dobbs T., Pau C.-P., Byers R., Green T. et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res. Hum. Retroviruses 2002; 18: 295–307. DOI: 10.1089/088922202753472874 18. Загрядская Ю.Е., Нешумаев Д.А., Кокотюха Ю.А., Мейрманова Е.М., Ольховский И.А., Пузырев В.Ф., Бурков А.Н., Уланова Т.И. Оценка новой тест-системы ДС-ИФА-ВИЧ-АТ-СРОК для определения вероятных сроков заражения вирусом иммунодефицита человека 1-го типа (ВИЧ-1). Эпидемиол. и инфекц. бол. 2015; 20(3): 23–7. Zagryadskaya Yu.E., Neshumaev D.A., Kokotyukha Yu.A., Meyrmanova E.M.. Olkhovskiy I.A.. Puzyrev V.F.. Burkov A.N.. Ulanova T.I. 19. Kouyos R., von Wyl V., Yerly S., Böni J., Rieder Ph.A., Joos B. et al. Ambiguous Nucleotide Calls From population based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection. Clin. Infect. Dis. 2011; 52(4): 532–9. DOI: 10.1093/cid/ciq164 20. Киреев Д.Е., Мурзакова А.В., Лопатухин А.Э., Покровская А.В., Шемшура А.Б., Кулагин В.В., Шипулин Г.А., Покровский В.В. Оценка эффективности определения длительности ВИЧ-инфекции путем анализа генетической вариабельности вируса. Инфекционные болезни 2017; 15(2): 61–6. DOI: 10.20953/1729-9225-2017-2-61-66 Kireev D.E., Murzakova A.V., Lopatukhin A.E., Pokrovskaya A.V., Shemshura A.B., Kulagin V.V., Shipulin G.A.. Pokrovskiy V.V.
Мурзакова Анастасия Вениаминовна – научный сотрудник научной группы разработки новых методов диагностики ВИЧ-инфекции и вирусных гепатитов ФБУН «Центральный НИИ эпидемиологии» Роспотребнадзора, Москва, Россия; e-mail: murzakova_a.v@mail.ru; ORCID: https://orcid.org/0000-0002-1390-8021
Киреев Дмитрий Евгеньевич – к.б.н., руководитель научной группы разработки новых методов диагностики ВИЧ-инфекции и вирусных гепатитов ФБУН «Центральный НИИ эпидемиологии» Роспотребнадзора, Москва, Россия; e-mail: dmitkireev@yandex.ru; ORCID: https://orcid.org/0000-0002-7896-2379